Research Roundtable: KIF1A.ORG Therapeutic Development Updates

For Research Network Members Only.

This Fall Research Roundtables are back in session! KIF1A.ORG’s Chief Science Officer Dr. Dylan Verden will provide an overview of current areas of KAND therapeutic development, discuss gaps in patient symptom management, and invite feedback on leveraging our Research Network’s resources for new projects.